Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226057 | SCV000286664 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2016-03-06 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001508113 | SCV001714048 | uncertain significance | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165614 | SCV003856896 | uncertain significance | Cardiovascular phenotype | 2023-01-23 | criteria provided, single submitter | clinical testing | The c.16552+5G>C intronic variant results from a G to C substitution 5 nucleotides after coding exon 63 in the TTN gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |